10513 related articles for article (PubMed ID: 1255799)
1. Inconsistent response of B16 melanoma to BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):803-10. PubMed ID: 1255799
[TBL] [Abstract][Full Text] [Related]
2. Non-specific and specific active immunotherapy in a B16 murine melanoma system.
Avent J; Vervaert C; Seigler HF
J Surg Oncol; 1979; 12(1):87-96. PubMed ID: 480953
[TBL] [Abstract][Full Text] [Related]
3. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
[TBL] [Abstract][Full Text] [Related]
4. Introduction of 65 kDa antigen of Mycobacterium tuberculosis to cancer cells enhances anti-tumor effect of BCG therapy.
Hara I; Sato N; Miyake H; Muramaki M; Hikosaka S; Kamidono S
Microbiol Immunol; 2004; 48(4):289-95. PubMed ID: 15107539
[TBL] [Abstract][Full Text] [Related]
5. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
Morton DL; Eilber FR; Holmes EC; Sparks FC; Ramming K
Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
Tokunaga T; Taguchi S; Chino F; Murohashi T
Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
[TBL] [Abstract][Full Text] [Related]
8. The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites.
Proctor JW; Auclair BG; Lewis MG
Eur J Cancer (1965); 1976 Mar; 12(3):203-10. PubMed ID: 939237
[No Abstract] [Full Text] [Related]
9. Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases.
Proctor JW; Auclair BG; Stokowski L; Mansell WA; Shibata H
Eur J Cancer (1965); 1977 Feb; 13(2):115-22. PubMed ID: 852486
[No Abstract] [Full Text] [Related]
10. Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.
Chee DO; Bodurtha AJ
Int J Cancer; 1974 Jul; 14(1):137-43. PubMed ID: 4617706
[No Abstract] [Full Text] [Related]
11. Immunotherapy of malignancies: current status.
Eilber FR; Holmes EC; Morton DL; Ramming KP; Sparks FC
AJR Am J Roentgenol; 1976 May; 126(5):1088-93. PubMed ID: 178234
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.
Tai J; Guclu A; Ghose T; Norvell S
Cancer Immunol Immunother; 1983; 15(1):47-53. PubMed ID: 6553507
[TBL] [Abstract][Full Text] [Related]
13. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
[TBL] [Abstract][Full Text] [Related]
14. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
[TBL] [Abstract][Full Text] [Related]
15. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
Jessup JM; Riggs CW; Hanna MG
Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
[No Abstract] [Full Text] [Related]
16. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
[TBL] [Abstract][Full Text] [Related]
17. Intratumor chemoimmunotherapy with mitomycin C and BCG in C3H/He mice transplanted with MH134.
Kasuga M; Sakita M; Yamane T; Torii T; Tamai M; Kageyama N; Fujita Y; Majima S
Gan; 1983 Feb; 74(1):148-54. PubMed ID: 6404684
[TBL] [Abstract][Full Text] [Related]
18. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
Lieberman R; Wybran J; Epstein W
Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
[TBL] [Abstract][Full Text] [Related]
19. BCG treatment of human tumour xenografts in athymic nude mice.
Pimm MV; Baldwin RW
Br J Cancer; 1978 Dec; 38(6):699-702. PubMed ID: 369588
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
Frenette M; Portelance V; Beaudet R
Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
